申请人:AUCKLAND UNISERVICES LIMITED
公开号:US11028064B2
公开(公告)日:2021-06-08
Disclosed are tricyclic heterocyclic compounds having kinase inhibitory activity, pharmaceutical compositions and kits comprising the compounds, and use of the compounds in the treatment of or in medicaments for the treatment of various diseases and conditions. In particular, disclosed are tricyclic heterocyclic compounds of the formula (I) having CSF-1R (c-FMS kinase) inhibitory activity and their use in the treatment of various diseases and conditions, such as those mediated by CSF-1R, including proliferative or neoplastic diseases and conditions, including cancers, and bone, inflammatory, and autoimmune diseases and conditions.
本发明公开了具有激酶抑制活性的三环杂环化合物、包含这些化合物的药物组合物和试剂盒,以及这些化合物在治疗各种疾病和病症中的用途或在治疗各种疾病和病症的药物中的用途。特别是,公开了具有CSF-1R(c-FMS激酶)抑制活性的式(I)三环杂环化合物及其在治疗各种疾病和病症中的用途,例如由CSF-1R介导的疾病和病症,包括增殖性或肿瘤性疾病和病症,包括癌症,以及骨、炎症和自身免疫性疾病和病症。